INVO Fertility (NASDAQ:IVF) and Presbia (OTCMKTS:LENSF) Financial Analysis

INVO Fertility (NASDAQ:IVF) and Presbia (OTCMKTS:LENSF) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends.

Earnings and Valuation

This table compares INVO Fertility and Presbia”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.53 million	0.93	-$9.10 million	($630.29)	0.00
Presbia	N/A	N/A	N/A	N/A	N/A

Presbia has lower revenue, but higher earnings than INVO Fertility.

Profitability

This table compares INVO Fertility and Presbia’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-417.02%	N/A	-92.42%
Presbia	N/A	N/A	N/A

Risk & Volatility

INVO Fertility has a beta of 2.66, meaning that its stock price is 166% more volatile than the S&P 500. Comparatively, Presbia has a beta of 5.91, meaning that its stock price is 491% more volatile than the S&P 500.

Insider and Institutional Ownership

12.0% of INVO Fertility shares are owned by institutional investors. 0.7% of INVO Fertility shares are owned by company insiders. Comparatively, 74.2% of Presbia shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent recommendations for INVO Fertility and Presbia, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1	0	0	1	2.50
Presbia	0	0	0	0	0.00

INVO Fertility currently has a consensus price target of $4.00, indicating a potential upside of 360.83%. Given INVO Fertility’s stronger consensus rating and higher probable upside, equities analysts clearly believe INVO Fertility is more favorable than Presbia.

Summary

INVO Fertility beats Presbia on 5 of the 9 factors compared between the two stocks.

About INVO Fertility

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.

About Presbia

Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in the United States, South Korea, Australia, Italy, the Netherlands, Ireland, Canada, and Germany. The company was founded in 2014 and is headquartered in Dublin, Ireland.